Adaptive gene- and pathway-trait association testing with GWAS summary statistics

Il-Youp Kwak1, Wei Pan1

  • 1Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN 55455, USA.

Summary

New adaptive gene and pathway association tests are developed for Genome-Wide Association Studies (GWAS) using only summary statistics. These methods enhance the analysis of large-scale genetic data without individual-level information, improving discovery of associated genes and pathways.

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.6K
Multiple Allele Traits01:49

Multiple Allele Traits

15.0K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
38.8K
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
70.4K
Polygenic Traits01:18

Polygenic Traits

11.4K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
76